交易中 08-24 11:44:28 美东时间
-0.080
-1.00%
今日重点评级关注:Truist Securities:维持AbCellera Biologics"买入"评级,目标价从12美元升至30美元;Stifel:维持Proficient Auto Logistics"买入"评级,目标价从9美元升至12美元
08-12 08:45
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
Wedbush analyst Michael Piccolo maintains TaskUs (NASDAQ:TASK) with a Outperform and lowers the price target from $12 to $9.
08-06 23:53
TaskUs shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
08-06 20:54
TaskUs (NASDAQ:TASK) raises FY2026 sales outlook from $1.210 billion-$1.240 billion to $1.220 billion-$1.240 billion vs $1.234 billion estimate.
08-06 04:49
TaskUs (NASDAQ:TASK) sees Q3 sales of $300.000 million-$302.000 million vs $306.413 million analyst estimate.
08-06 04:49
U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Thursday. Shares of Rollins Inc (NYSE:ROL) fell sharply in pre-market trading after the company reported worse-than-expected second-quarter financial results. Rollins reported quarterly earnings of 32 cents...
07-23 20:03
Brings More Than Two Decades of Global Financial Leadership and Deep Expertise Across Public and Private Technology Services Organizations TaskUs, Inc. (NASDAQ:TASK) ("TaskUs" or the "Company"), a leading provider of outsourced digital services and next-generation customer experience to the world’s ...
06-23 04:07
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Wedbush analyst Michael Piccolo maintains TaskUs (NASDAQ:TASK) with a Outperform and lowers the price target from $14 to $12.
05-07 22:51